Patents by Inventor Connie WESTHOFF

Connie WESTHOFF has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240018471
    Abstract: Provided herein are engineered red blood cells expressing rare blood antigen group profiles, and methods of making use the same, are described. Also provided are recombinant reagent red blood cells that express or lack the expression of at least one protein (e.g., a blood group antigen) on its surface and uses thereof.
    Type: Application
    Filed: June 6, 2023
    Publication date: January 18, 2024
    Applicants: THE CHILDREN'S HOSPITAL OF PHILADELPHIA, NEW YORK BLOOD CENTER, INC.
    Inventors: Stella CHOU, Connie WESTHOFF
  • Patent number: 11708559
    Abstract: Provided herein are engineered red blood cells expressing rare blood antigen group profiles, and methods of making use the same, are described. Also provided are recombinant reagent red blood cells that express or lack the expression of at least one protein (e.g., a blood group antigen) on its surface and uses thereof.
    Type: Grant
    Filed: October 29, 2018
    Date of Patent: July 25, 2023
    Assignees: The Children's Hospital of Philadelphia, New York Blood Center, Inc.
    Inventors: Stella Chou, Connie Westhoff
  • Publication number: 20220137074
    Abstract: The present invention relates to methods of identifying suitable donor blood for cancer patients receiving anti-CD38 antibodies as treatment. In particular, the present invention addresses problems associated with crossmatching patient and donor blood when the patient blood comprises anti-CD38 antibodies that interfere with crossmatching methods of the art.
    Type: Application
    Filed: September 10, 2021
    Publication date: May 5, 2022
    Inventors: Alexander Anthony Zukiwski, Connie Westhoff
  • Publication number: 20210355440
    Abstract: Provided herein are engineered red blood cells expressing rare blood antigen group profiles, and methods of making use the same, are described. Also provided are recombinant reagent red blood cells that express or lack the expression of at least one protein (e.g., a blood group antigen) on its surface and uses thereof.
    Type: Application
    Filed: October 29, 2018
    Publication date: November 18, 2021
    Applicants: THE CHILDREN'S HOSPITAL OF PHILADELPHIA, NEW YORK BLOOD CENTER, INC.
    Inventors: Stella CHOU, Connie WESTHOFF